Generic drug
Tramadol price, strengths & recalls
Pharmacies pay $0.78 for 30 tablets of Tramadol 50 mg tablet this week, and from $0.78 to $295.60 across its 8 priced strengths and forms. 40 manufacturers make it. 2 recalls are ongoing. Its official label last changed on November 21, 2024.
2 open recallsGeneric- Fair cash price
- $11.40
- Strengths
- 8
- Makers
- 40
- Updated
- Nov 11
Tramadol price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 100 mg (24 hr) extended-release capsule | $7.71 | $231.23 / 30 capsules | ||
| 200 mg (24 hr) extended-release capsule | $9.85 | $295.60 / 30 capsules | ||
| 100 mg (24 hr) extended-release tablet | $0.8901 | $26.70 / 30 tablets | ||
| 200 mg extended-release tablet | Not priced this week | |||
| 200 mg (24 hr) extended-release tablet | $1.39 | $41.61 / 30 tablets | ||
| 300 mg (24 hr) extended-release tablet | $2.07 | $61.97 / 30 tablets | ||
| 5 mg/mL oral solution | Not priced this week | |||
| 25 mg tablet | $3.38 | $101.37 / 30 tablets | ||
| 50 mg tablet | $0.0260 | $0.78 / 30 tablets | ||
| 100 mg tablet | $1.10 | $33.02 / 30 tablets | ||
The lowest cost per tablet is 50 mg tablet at $0.0260. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 12 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Tramadol
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
TRAMADOL HYDROCHLORIDE TABLETS. These highlights do not include all the information needed to use TRAMADOL HYDROCHLORIDE TABLETSsafely and effectively. See full prescribing information for TRAMADOL HYDROCHLORIDE TABLETS.TRAMADOL HYDROCHLORIDE tablets, for oral use, C-IV Initial U.S. Approval: 1995
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE TABLETS
Addiction, Abuse, and Misuse
Because the use oftramadol hydrochloride tabletsexposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions
[see Warnings and Precautions (
5.1)]
.
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use oftramadol hydrochloride tablets, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration oftramadol hydrochloride tabletsare essential
[see Warnings and Precautions (
5.2)]
.
Accidental Ingestion
Accidental ingestion of even one dose oftramadol hydrochloride tablets, especially by children, can result in a fatal overdose of tramadol
[see Warnings and Precautions (
5.2)]
.
Risks From Concomitant Use with Benzodiazepines or Other CNS Depressants
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing oftramadol hydrochloride tabletsand benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate
[see Warnings and Precautions (
5.3), Drug Interactions (
7)]
.
Neonatal Opioid Withdrawal Syndrome (NOWS)
If opioid use is required for an extended period of time in a pregnant woman, advise the patient of the risk of NOWS, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery
[see Warnings and Precautions (
5.4)]
.
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription
[see Warnings and Precautions (
5.5)]
.
Ultra-Rapid Metabolism of Tramadol and Other Risk Factors for Life-Threatening Respiratory Depression in Children
Life-threatening respiratory depression and death have occurred in children who receivedtramadol. Some of the reported cases followed tonsillectomy and/or adenoidectomy; in at least one case, the child had evidence of being an ultra-rapid metabolizer of tramadol due to a CYP2D6 polymorphism
[see Warnings and Precautions (
5.6)]
. Tramadol
hydrochloride tabletsare contraindicated in children younger than 12 years of age and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy
[see Contraindications (
4)]
. Avoid the use of tramadol
hydrochloride tabletsin adolescents 12 to 18 years of age who have other risk factors that may increase their sensitivity to the respiratory depressant effects of tramadol
[see Warnings and Precautions (
5.6)]
.
Interactions with Drugs Affecting Cytochrome P450 Isoenzymes
The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol are complex. Use of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol hydrochloride tablets requires careful consideration of the effects on the parent drug, tramadol, and the active metabolite, M1
[see Warnings and Precautions (
5.7); Drug Interactions (
7)]
.
WARNING:
SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE TABLETS
See full prescribing information for complete boxed warning.
Tramadol hydrochloride tablets expose users to the risks of addiction, abuse and misuse, which can lead to overdose and death. Assess each patient's risk prior to prescribing tramadol hydrochloride tablets, and monitor regularly for these behaviors or conditions. (
5.1)
Serious, life-threatening, or fatal respiratory depression may occur. Monitor closely, especially during initiation or following a dose increase. (
5.2)
Accidental ingestion of tramadol hydrochloride tablets, especially by children, can result in a fatal overdose of tramadol. (
5.2)
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate; limit dosages and durations to the minimum required; and follow patients for signs and symptoms of respiratory depression and sedation. (
5.3,
7)
Prolonged use of tramadol hydrochloride tablets, during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life threatening if not recognized and treated. If prolonged opioid use is required in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available. (
5.4)
To ensure that the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the Food and Drug Administration (FDA) has required a Risk Evaluation and Mitigation Strategy (REMS) for these products. (
5.5)
Life-threatening respiratory depression and death have occurred in children who received tramadol. Some of the reported cases followed tonsillectomy and/or adenoidectomy; in at least one case, the child had evidence of being an ultra-rapid metabolizer of tramadol due to a CYP2D6 polymorphism. (
5.6)
Tramadol hydrochloride tablets are contraindicated in children younger than 12 years of age and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (4). Avoid the use of tramadol hydrochloride tablets in adolescents 12 to 18 years of age who have other risk factors that may increase their sensitivity to the respiratory depressant effects of tramadol. (
5.6)
The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol are complex. Use of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol hydrochloride tablets requires careful consideration of the effects on the parent drug, tramadol, and the active metabolite, M1. (
5.7,
7)
Recent major changes (as listed on the label)
Boxed Warning 9/2023
Indications and Usage (1) 4/2023
Dosage and Administration (2.1, 2.3) 4/2023
Warnings and Precaution (5.6) 4/2023
Boxed Warning 9/2023
Indications and Usage (
1) 4/2023
Dosage and Administration (
2.1,
2.3,
2.4) 4/2023
Warnings and Precaution (
5.6) 4/2023
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022370 · Cipher Pharms Inc
- First approved
- May 7, 2010 (16 years ago)
- Latest approved change
- June 18, 2026
- Approved label
- PDF, Jan 6, 2026
- Generic makers
- 12 approved generic applications on the market
Tramadol questions
How much does tramadol cost without insurance?
Pharmacies pay about $0.78 for 30 tablets of tramadol 50 mg tablet ($0.0260 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $11.40. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is tramadol in shortage?
No shortage is reported for tramadol right now. We check the national shortage list every day.
Has tramadol been recalled?
12 recalls on record, 2 ongoing. Recalls name specific lots - check yours.
When did the tramadol label last change?
The official label was last updated on November 21, 2024 (version 1). See what changed.
Talk about tramadol
No comments yet. Questions, tips, what worked for you - start the conversation.